Apellis Pharmaceuticals Inc (APLS) Stock: Understanding the Volatility
The stock of Apellis Pharmaceuticals Inc (APLS) has gone down by -5.21% for the week, with a -19.87% drop in the past month and a
The stock of Apellis Pharmaceuticals Inc (APLS) has gone down by -5.21% for the week, with a -19.87% drop in the past month and a
The stock price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has plunged by -3.61 when compared to previous closing price of 60.69, but the company has
The stock of Apellis Pharmaceuticals Inc (APLS) has gone down by -4.86% for the week, with a -10.59% drop in the past month and a
The stock price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has plunged by -3.32 when compared to previous closing price of 71.73, but the company has
and a 36-month beta value of 0.93. The public float for APLS is 96.62M, and at present, short sellers hold a 11.04% of that float.
Apellis Pharmaceuticals Inc (NASDAQ: APLS)’s stock price has increased by 8.95 compared to its previous closing price of 62.56. However, the company has seen a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.